235 related articles for article (PubMed ID: 10501554)
21. Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma.
Giuffrida A; Piomelli D
FEBS Lett; 1998 Feb; 422(3):373-6. PubMed ID: 9498819
[TBL] [Abstract][Full Text] [Related]
22. Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404.
Giuffrida A; Rodriguez de Fonseca F; Nava F; Loubet-Lescoulié P; Piomelli D
Eur J Pharmacol; 2000 Nov; 408(2):161-8. PubMed ID: 11080522
[TBL] [Abstract][Full Text] [Related]
23. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.
Derocq JM; Bouaboula M; Marchand J; Rinaldi-Carmona M; Ségui M; Casellas P
FEBS Lett; 1998 Apr; 425(3):419-25. PubMed ID: 9563506
[TBL] [Abstract][Full Text] [Related]
24. Quantitative analysis of anandamide and related acylethanolamides in human seminal plasma by ultra performance liquid chromatography tandem mass spectrometry.
Amoako AA; Marczylo TH; Lam PM; Willets JM; Derry A; Elson J; Konje JC
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(31):3231-7. PubMed ID: 21056015
[TBL] [Abstract][Full Text] [Related]
25. Plasma endocannabinoid levels in multiple sclerosis.
Jean-Gilles L; Feng S; Tench CR; Chapman V; Kendall DA; Barrett DA; Constantinescu CS
J Neurol Sci; 2009 Dec; 287(1-2):212-5. PubMed ID: 19695579
[TBL] [Abstract][Full Text] [Related]
26. Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide--targets for drug development?
Fowler CJ; Jacobsson SO
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):193-200. PubMed ID: 12052035
[TBL] [Abstract][Full Text] [Related]
27. Cannabinoid/anandamide system and schizophrenia: is there evidence for association?
Schneider U; Leweke FM; Mueller-Vahl KR; Emrich HM
Pharmacopsychiatry; 1998 Jul; 31 Suppl 2():110-3. PubMed ID: 9754842
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat.
Helyes Z; Németh J; Thán M; Bölcskei K; Pintér E; Szolcsányi J
Life Sci; 2003 Sep; 73(18):2345-53. PubMed ID: 12941436
[TBL] [Abstract][Full Text] [Related]
29. Diurnal variation of arachidonoylethanolamine, palmitoylethanolamide and oleoylethanolamide in the brain of the rat.
Murillo-Rodriguez E; Désarnaud F; Prospéro-García O
Life Sci; 2006 May; 79(1):30-7. PubMed ID: 16434061
[TBL] [Abstract][Full Text] [Related]
30. Ocular activity of topically administered anandamide in the rabbit.
Mikawa Y; Matsuda S; Kanagawa T; Tajika T; Ueda N; Mimura Y
Jpn J Ophthalmol; 1997; 41(4):217-20. PubMed ID: 9304433
[TBL] [Abstract][Full Text] [Related]
31. Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans.
Thieme U; Schelling G; Hauer D; Greif R; Dame T; Laubender RP; Bernhard W; Thieme D; Campolongo P; Theiler L
Drug Test Anal; 2014; 6(1-2):17-23. PubMed ID: 24424856
[TBL] [Abstract][Full Text] [Related]
32. Familial abnormalities of endocannabinoid signaling in schizophrenia.
Koethe D; Pahlisch F; Hellmich M; Rohleder C; Mueller JK; Meyer-Lindenberg A; Torrey EF; Piomelli D; Leweke FM
World J Biol Psychiatry; 2019 Feb; 20(2):117-125. PubMed ID: 29521179
[TBL] [Abstract][Full Text] [Related]
33. The endogenous cannabinoid anandamide, but not the CB2 ligand palmitoylethanolamide, prevents the viscero-visceral hyper-reflexia associated with inflammation of the rat urinary bladder.
Jaggar SI; Sellaturay S; Rice AS
Neurosci Lett; 1998 Sep; 253(2):123-6. PubMed ID: 9774165
[TBL] [Abstract][Full Text] [Related]
34. Endocannabinoids and cannabinoid analogues block human cardiac Kv4.3 channels in a receptor-independent manner.
Amorós I; Barana A; Caballero R; Gómez R; Osuna L; Lillo MP; Tamargo J; Delpón E
J Mol Cell Cardiol; 2010 Jan; 48(1):201-10. PubMed ID: 19616555
[TBL] [Abstract][Full Text] [Related]
35. A second endogenous cannabinoid that modulates long-term potentiation.
Stella N; Schweitzer P; Piomelli D
Nature; 1997 Aug; 388(6644):773-8. PubMed ID: 9285589
[TBL] [Abstract][Full Text] [Related]
36. Endogenous cannabinoid receptor agonists inhibit neurogenic inflammations in guinea pig airways.
Yoshihara S; Morimoto H; Ohori M; Yamada Y; Abe T; Arisaka O
Int Arch Allergy Immunol; 2005 Sep; 138(1):80-7. PubMed ID: 16103691
[TBL] [Abstract][Full Text] [Related]
37. Plant cannabinoids: a neglected pharmacological treasure trove.
Mechoulam R
Br J Pharmacol; 2005 Dec; 146(7):913-5. PubMed ID: 16205721
[TBL] [Abstract][Full Text] [Related]
38. Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis.
Di Filippo M; Pini LA; Pelliccioli GP; Calabresi P; Sarchielli P
J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1224-9. PubMed ID: 18535023
[TBL] [Abstract][Full Text] [Related]
39. Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia.
Müller-Vahl KR; Emrich HM
Expert Rev Neurother; 2008 Jul; 8(7):1037-48. PubMed ID: 18590475
[TBL] [Abstract][Full Text] [Related]
40. Isolation and structure of a brain constituent that binds to the cannabinoid receptor.
Devane WA; Hanus L; Breuer A; Pertwee RG; Stevenson LA; Griffin G; Gibson D; Mandelbaum A; Etinger A; Mechoulam R
Science; 1992 Dec; 258(5090):1946-9. PubMed ID: 1470919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
